Sunday, November 03, 2019 4:07:19 PM
Show:
Date Brokerage Action Rating Price Target Impact on Share Price Details
10/25/2019 Goldman Sachs Group Set Price Target Buy $18.00 N/A
9/6/2019 Cowen Reiterated Rating Buy High
8/19/2019 Svb Leerink Initiated Coverage Outperform $26.00 High
8/19/2019 Leerink Swann Initiated Coverage Outperform $26.00 High
5/30/2019 Citigroup Initiated Coverage Buy $25.00 High
4/11/2019 Evercore ISI Initiated Coverage Outperform High
2/13/2019 Barclays Upgrade Equal Weight ? Overweight $22.00 ? $25.00 High
2/11/2019 JMP Securities Reiterated Rating Buy $25.00 Low
9/13/2018 JPMorgan Chase & Co. Initiated Coverage Overweight ? Overweight $39.00 High
11/10/2017 Robert W. Baird Reiterated Rating Buy $20.00 N/A
(Data available from 11/3/2017 forward)
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM